Irace, Concetta <br/><br/>
Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.  [electronic resource] 

 -  Diabetes, obesity & metabolism  07 2020 
 - 1056-1061 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.13993  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Blood Glucose<br/>Blood Glucose Self-Monitoring<br/>Diabetes Mellitus, Type 1--drug therapy<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Insulin<br/>Italy<br/>Middle Aged<br/>Prospective Studies<br/>Young Adult